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2Liverpool John Moores University, Liverpool, UKObjective Previous research suggests that ecstasy users are impaired in processing visuospatial information. However, for the most part,
the deﬁcits observed appear to involve the recall and recognition of complex visual and geometric patterns. The present research sought to
determine whether ecstasy use was associated with deﬁcits in serial spatial recall and visuospatial working memory (VSWM).
Methods Thirty‐eight current ecstasy/polydrug users, 16 previous ecstasy/polydrug users and 52 non ecstasy users completed serial simple
spatial recall and VSWM tasks.
Results Both the current and previous users of ecstasy exhibited deﬁcits on the VSWM task. Following controls for group differences in
aspects of cannabis and cocaine use, the overall group effect fell to just below statistical signiﬁcance. However, the difference contrast
comparing users with nonusers continued to demonstrate a statistically signiﬁcant ecstasy‐related VSWM deﬁcit.
Conclusions Ecstasy users were impaired in processing visuospatial information especially under conditions of high processing demand.
The results are consistent with ecstasy‐related impairment either in the short‐term posterior parietal and occipital area store or the dorsolateral
prefrontal cortex processes, which augment it under conditions of higher processing demands. Further research is needed to pinpoint the
actual source of the ecstasy/polydrug‐related VSWM deﬁcits that have been observed here and elsewhere. Copyright © 2011 John Wiley &
Sons, Ltd.
key words—ecstasy; cocaine; spatial working memory; substance misuseINTRODUCTION
The purpose of the present study is to establish
whether ecstasy users might be impaired in visuospa-
tial processing, more speciﬁcally, the visuospatial
working memory (VSWM) system. There is an
emerging body of evidence to suggest that ecstasy
use may be associated with visuospatial deﬁcits. Much
of the existing research has focussed on recall and
recognition. For example, Gouzoulis‐Mayfrank et al.
(2000) found that users exhibited deﬁcits on the
immediate recall (but not the subsequent learning) of
previously presented complex visual stimuli. Ecstasy/
polydrug users have also been found to be less
accurate in a visual discrimination matching to sample
task (McCann et al., 2007). Deﬁcits have also been
observed on a simple visual recall task (Fox et al.,
2001). Furthermore, Yip and Lee (2005) observed
deﬁcits among ecstasy/polydrug users in the immedi-
ate and delayed recall of complex visual stimuli (and
in ﬁgural ﬂuency) and de Sola Llopis et al. (2008)*Correspondence to: J. E. Fisk, PhD, Professor, Department of Psychology,
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Copyright © 2011 John Wiley & Sons, Ltd.found that heavy users were impaired relative to
nonusers on a similar measure.
In relation to recognition, Verkes et al. (2001) found
that both heavy and moderate ecstasy users were
impaired relative to nonusers in their ability to recognise
previously presented (serially and simultaneously)
geometric ﬁgures. Similarly, Gouzoulis‐Mayfrank
et al. (2000) found that ecstasy users were impaired
in identifying targets (previously memorised complex
visual stimuli) from similar non targets. Fox et al.
(2002) also found that ecstasy users did signiﬁcantly
worse in a pattern recognition task (selecting a
previously seen stimulus paired with a novel
stimulus).
However, not all studies have found ecstasy‐related
impairments. For example, McCann et al. (1999)
failed to observe ecstasy‐related deﬁcits in the
recognition of a previously presented matrix‐type
ﬁgure, and likewise, the recall of complex geometric
ﬁgures was found to be unaffected by ecstasy use
(Bhattachary and Powell, 2001). More recently, in a
longitudinal prospective study, Schilt et al. (2007)
found that, relative to those who did not become
ecstasy users, individuals who subsequently startedReceived 23 August 2010
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delayed recall and learning of complex ﬁgures.
Similarly, Bedi and Redman (2008) found that
individual differences on the combined copying,
immediate and delayed recall scores of the Rey
Complex Figures test were unrelated to any aspect
of ecstasy or other illicit drug use, and Halpern et al.
(2004) also failed to observe ecstasy‐related deﬁcits on
the same measure. Finally, Rodgers (2000) found that
ecstasy users were unimpaired on a measure of
immediate visual memory (a composite based on the
recognition of abstract designs, the reproduction of
simple geometric ﬁgures and visual associative
learning: pairing colours with abstract line drawings).
Thus, to summarise, the evidence for ecstasy‐related
deﬁcits in the recall and recognition of visual stimuli is
mixed.
Aside from the possibility of deﬁcits in recall and
recognition, a number of studies have focussed on
more prefrontal tasks that utilise executive resources.
Here again, there is a degree of ambiguity in the
results. In relation to the ability to mentally rotate
objects, McCann et al. (1999) and Schilt et al. (2007)
failed to observe ecstasy‐related deﬁcits although in a
later study, McCann et al. (2007) did observe ecstasy‐
related impairments in mental rotation. Furthermore,
utilising a spatial working memory (SWM) task in
which participants search for tokens hidden in a
computer‐generated array of spatial locations, (boxes),
Fox et al. (2002) found that ecstasy users produced
more errors (by returning to a box where a previous
token was hidden or looking repeatedly in the same
empty box for a concealed token in a single trial).
Furthermore, performance was especially impaired on
the more difﬁcult trials with more boxes. Using the
same measure, Semple et al. (1999) found that
although users did not differ signiﬁcantly from
nonusers (which the authors attributed to limited
statistical power), there was a signiﬁcant association
between lifetime ecstasy use and the number of errors
on the task. Aside from SWM, in their study, Fox et al.
(2002) found that although visuospatial associative
learning (pairing complex abstract stimuli with speciﬁc
spatial locations) was unimpaired, there was in fact a
trend whereby ecstasy users performed worse at the
more difﬁcult levels (Fox et al., 2002).
The Corsi blocks procedure is a long‐standing
paradigm used for assessing an individual’s simple
spatial span. Results have been inconsistent in relation
to ecstasy use with deﬁcits among users being identiﬁed
byVerkes et al. (2001) andHanson and Luciana (2010).
However, ecstasy users in Gouzoulis‐Mayfrank et al.’s
(2000) study did not show impairment on this measure.Copyright © 2011 John Wiley & Sons, Ltd.More interestingly, backward spatial span is believed to
rely more heavily on prefrontal executive resources,
and a number of studies have tested ecstasy users on this
measure. For example, although heavy users (but not
light users) were signiﬁcantly impaired on backward
span, this was no longer signiﬁcant following controls
for a family history of substance abuse (Halpern et al.,
2004). However, in the longitudinal study of de Sola
Llopis et al. (2008), ecstasy users were worse on the
backward span measure, and although the difference
only approached signiﬁcance at baseline, linear
mixed models analysis for the longitudinal aspect
over 0–24months showed that ecstasy users exhibited a
signiﬁcant backward span deﬁcit. More recently,
Hanson and Luciana (2010) compared polydrug users
with non drug controls and found that the former group
were impaired on an SWMmeasure but that the level of
ecstasy use was unrelated to the magnitude of the
impairment.
There is some evidence therefore of the effects of
ecstasy use on visual processing. However, previous
research has tended to focus on recall and recognition
of visual stimuli, which presumably recruit occipital
and medial temporal resources rather than prefrontal
processes. Furthermore, the tests of VSWM that have
previously been used have generally not captured the
full range of processes that have been explored in the
verbal domain. For example, VSWM involves not
only the maintenance of static visual stimuli but also
the processing of dynamic sequential spatial informa-
tion and manipulating the contents of temporary visual
stores. Neuroimaging (functional magnetic resonance
imaging) research suggests that the maintenance
aspects are supported by a limited capacity store in
the posterior parietal and occipital cortices with the
incremental processing component loading on more
anterior locations in the prefrontal cortex (Martin
et al., 2008). In previous research from our own
laboratory (Wareing et al., 2004, 2005), we demon-
strated that although ecstasy/polydrug users performed
similarly to non ecstasy users on simple span tasks, that
is, recalling a sequence of spatial locations, when a
processing component was added, in which partici-
pants were required to make a visual judgement while
simultaneously maintaining a sequence of spatial
locations, an ecstasy/polydrug‐related deﬁcit was
apparent. Furthermore, it is noteworthy that this deﬁcit
persisted in previous users of the drug. However, these
studies suffered from a number of limitations. First, the
spatial stimuli were displayed in a matrix arrangement.
This has been shown to facilitate verbal recoding
(Brown et al., 2006), leaving open the question on
whether the deﬁcits that were observed were actuallyHum. Psychopharmacol Clin Exp 2011; 26: 313–321.
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that matrix displays allow the utilisation of structural
information from long‐term memory, for example,
visuospatial templates (Dean et al., 2008); thus, the
deﬁcits observed might have reﬂected group differ-
ences in the ability to retrieve this information.
The present study utilises an SWM measure that is
an analogue of the verbal working memory measures
that have been developed such as operation span
(Miyake et al., 2000). Like operation span, it requires
the retention of serial‐order information, and it
includes a secondary processing task. It also relates
to existing measures of serial spatial memory in that it
uses a Corsi‐type irregular display. Thus, participants
are required to maintain a spatial sequence of
increasing length while simultaneously performing a
visual discrimination task. Using the same measure,
Fisk and co‐workers have previously demonstrated an
SWM deﬁcit among adults with dyslexia and among
older adults (Fisk, 2004; Smith‐Spark and Fisk, 2007).
In the present study, ecstasy/polydrug users are
predicted to exhibit a deﬁcit speciﬁcally on the
SWM measure with simple spatial span expected to
reveal no drug‐related deﬁcits. Thus, an interaction is
predicted between user group and SWM processing
demands (simple span = low demand; SWM task =
high demand). This expectation will be tested in a
mixed analysis of variance design. The deﬁcit is
predicted to be present in both current and former
ecstasy/polydrug users compared with nonusers, and
the two user groups are expected to perform similarly.
METHOD
Participants
Thirty‐eight current ecstasy/polydrug users (men = 19,
women = 19), 16 previous ecstasy/polydrug users who
had not used ecstasy for at least 6months (men = 1,
women = 15) and 52 non ecstasy users (men = 8,
women = 44) took part in this investigation. The
participants were recruited via direct approach to
university students and via the snowball technique,
that is, word‐of‐mouth referral (Solowij et al., 1992).
Individuals with a medical diagnosis of drug depen-
dence or those injecting illicit drugs were excluded
from the study. Current pattern and history of drug use
for the three groups is displayed in Table 1. For current
ecstasy/polydrug users, median period of abstinence
was 40, 2, 3 and 2.5weeks for amphetamine, cannabis,
cocaine and ecstasy, respectively. For previous ecstasy/
polydrug, the equivalent abstinence ﬁgures were 260,
28, 12 and 60weeks for amphetamine, cannabis,
cocaine and ecstasy, respectively. For non ecstasyCopyright © 2011 John Wiley & Sons, Ltd.users, the median period of abstinence was 24 and
8weeks for cannabis and cocaine, respectively.
Inspection of Table 2 reveals that the three groups
were similar in terms of average age and years of
education. Overall group differences were statistically
signiﬁcant for the Ravens (IQ) measure, p< 0.05; and
for alcohol, p < 0.01; and tobacco consumption,
p< 0.05. Difference contrasts revealed that nonusers
consumed signiﬁcantly less alcohol and tobacco
compared with ecstasy/polydrug users, p< 0.05 in
both cases. On the Ravens measure, current users
scored signiﬁcantly higher than previous users, and
they also smoked signiﬁcantly fewer cigarettes per
day, p < 0.01. Compared with current users, previous
users had fewer years of education and consumed
fewer units of alcohol although these differences only
approached statistical signiﬁcance.
Materials
The prior history of illicit drug consumption was
assessed using a background drug‐use questionnaire
that has been used extensively in previous research
from our laboratory (e.g. Fisk et al., 2005). These data
were used to estimate the total lifetime use for each
drug (e.g. ecstasy, cannabis, amphetamines, cocaine).
Period of abstinence, frequency of use and recent use
(in the previous 10 and 30 days) were also assessed.
Fluid intelligence was measured via Raven’s Progres-
sive Matrices (Raven et al., 1998), and the number of
years of education, the participant’s age and gender
and their current use of cigarettes and alcohol were
recorded.
Spatial working memory span. The test was developed
by Fisk (2004) as a measure of VSWM and has been
used subsequently for this purpose (e.g. Smith‐Spark
and Fisk, 2007). Twelve Corsi‐style boxes appear on a
PC monitor, in a random array, with a line running
horizontally across the middle of the screen so that there
is an even distribution of six boxes in each half of the
screen. Five of the boxes are highlighted for 3 s, four of
which contain Xs and one of which contains Os. First,
the participants were required to indicate whether there
were more highlighted boxes in the top half or the
bottom half of the screen by pointing to one of two
boxes positioned, respectively, in the top right hand
corner and the bottom right hand corner. In addition, the
participants were asked to remember the location of the
box that was highlighted with Os and after the Corsi‐
style pattern was removed, to record the position of the
‘O’ cell in an answer booklet. They did this by writing
the number 1 in the appropriate location. There were
three trials of this type, after which, the number ofHum. Psychopharmacol Clin Exp 2011; 26: 313–321.
DOI: 10.1002/hup
Table 1. Indicators of drug use for ecstasy users and nonusers
Current users Previous users Non ecstasy users
Mean SD n Mean SD n Mean SD n
Lifetime dose
Amphetamine (g) 95.50 124.74 12 469.33 410.47 3 – – –
Cannabis ( joints) 3009.15 4465.89 33 2321.85 4173.90 13 145.44 270.53 17
Cocaine (lines) 1347.84 1836.88 25 366.22 505.20 9 763.50 1175.96 4
Ecstasy (tablets) 699.71 1288.82 38 161.13 268.59 16 – – –
Use in previous 30 days
Amphetamine (g) 0.50 1.17 12 0 0 3 – – –
Cannabis ( joints) 18.95 45.44 33 2.54 6.81 13 4.12 13.55 17
Cocaine (lines) 10.60 14.22 25 4.44 10.67 9 2.00 4.00 4
Ecstasy (tablets) 6.11 12.49 38 0 0 16 – – –
Use in previous 10 daysa
Amphetamine (g) 1.00 – 1 – – – – – –
Cannabis ( joints) 3.33 3.60 18 1.50 0.71 2 5.00 1.41 2
Cocaine (lines) 16.83 12.27 6 8.00 0.00 2 16.00 – 1
Ecstasy (tablets) 1.43 0.53 7 – – – – – –
Frequency of use (times per week)
Amphetamine 0.12 0.29 12 0 0 4 – – –
Cannabis 1.11 1.88 33 0.33 0.85 13 0.53 1.26 17
Cocaine 0.41 0.49 25 0.28 0.39 8 0.58 0.49 4
Ecstasy 0.38 0.49 38 0.02 0.06 16 – – –
Weeks since last use
Amphetamine 78.30 114.37 15 346.67 150.11 3 – – –
Cannabis 28.20 76.39 33 59.66 76.96 12 91.44 141.87 18
Cocaine 17.55 54.81 32 28.75 35.31 9 7.11 5.92 5
Ecstasy 5.47 6.73 38 114.44 99.99 16 – – –
Alcohol (units per week) 18.30 12.64 38 12.53 9.46 15 9.58 9.49 48
Tobacco (cigarettes per day) 6.88 4.81 16 16.14 11.65 7 6.25 5.88 12
aData relate to only those individuals actually using within the previous 10 days.
SD, standard deviation.
Table 2. Average age, intelligence, years of education for ecstasy user and nonusers
Current users Previous users Non ecstasy users p
Mean SD n Mean SD n Mean SD n Group Nonuser versus user Current versus previous
Age (years) 21.45 2.53 38 22.25 4.73 16 20.92 2.91 52 ns ns ns
Intelligence (Ravens, max= 60) 45.76 8.34 37 40.31 12.44 16 46.21 7.07 52 <0.05 0.070 <0.05
Education (years) 15.58 2.40 38 14.38 3.93 16 15.65 1.51 51 ns ns 0.088
SD, standard deviation.
316 j. e. ﬁsk ET AL.consecutive Corsi displays increased to two, each one
containing 12 boxes in the same spatial arrangement,
ﬁve of which were highlighted. As each display was
presented, the participant was required to point to the
top or bottom according to where the majority of boxes
were located. The participant was also required to
remember the location of the ‘O’ cell in each Corsi
display and after the displays were removed to indicate
the locations in the answer book by writing in the
appropriate locations the number 1 for the ‘O’ cell from
the ﬁrst display and the number 2 for the ‘O’ cell from
the second display. As the task proceeded, the number
of Corsi displays presented consecutively increased byCopyright © 2011 John Wiley & Sons, Ltd.one every three trials. After each display, the participant
completed the pointing task, and after all the displays in
that particular trial had been presented, the participant
recorded the position of the ‘O’‐ﬁlled cells in order in
the answer book by writing 1, 2, 3 and so forth. In total,
there were six levels to the task with the number of
Corsi displays presented in a trial gradually increasing
from one to six. In order to achieve a particular level, the
participant was required to be correct in at least two of
the three trials. The response was deemed to be correct
if the locations of the ‘O’‐ﬁlled cells, and their serial
order were successfully recalled, and the pointing
component of the task had been completed correctly.Hum. Psychopharmacol Clin Exp 2011; 26: 313–321.
DOI: 10.1002/hup
317visuospatial working memory in ecstasy usersThe maximum level that was achieved was deﬁned as
the participant’s SWM span.
Simple spatial span. The participants were presented
with a random pattern consisting of 12 blank squares
arranged in a Corsi‐type fashion on a computer
monitor. On each trial, a certain number of squares
would be highlighted (ﬁlled with Xs) in sequence each
for 2 s. As each new square was highlighted, the
previous one went blank. The participants then
attempted to recall the position of each of the squares
so highlighted. They did this by indicating the
positions of the squares and the order in which they
were ﬁlled in an answer book provided for this
purpose. For the ﬁrst three trials, only one position
was highlighted. Subsequently, for each block of three
trials, the number of positions highlighted increased
by one. Thus, there were three trails with two
positions, three trails with three positions, three trials
with four positions and so forth. The participant
proceeded to the next level until he or she failed to
recall the positions on at least two out of three trials.
The participants’ simple spatial span was the maxi-
mum level achieved.
Procedure
The participants were informed of the general purpose of
the experiment and their right to withdraw any time.
Informed consentwas obtained verbally, after which, the
drug‐use questionnaire was administered ﬁrst, followed
by the Raven’s Progressive Matrices intelligence test
and the age/education questionnaire. Next, the simple
spatial span task was administered, after which,
participants completed a practice version of the SWM
task. This consisted of three trials at level one, followed
by three trials at level two. After this, the full version of
the SWM task was administered. The participants were
fully debriefed, paid 20 UK pounds in Tesco store
vouchers and given drug education leaﬂets. The
University of Central Lancashire’s Ethics Committee
approved the study, which conforms to the ethical
guidelines of the British Psychological Society and the
Declaration of Helsinki (as amended in Seoul in 2008)1 .
Design and statistics
A mixed design was employed with drug users as the
between‐participants factor (current, previous and non
ecstasy user) and processing demands as the within‐
participants factor (simple spatial versus SWM). This1 In order to address the concerns of the illicit drug users within our sample
in relation to protecting their identity and anonymity, consent was obtained
verbally rather than in writing.
Copyright © 2011 John Wiley & Sons, Ltd.was followed by a series of analyses of covariance
with SWM as the dependent variable, drug user as the
between participants independent variable and various
other variables introduced as covariates. Differences
between the groups were investigated through differ-
ence (reverse Helmert) contrast analyses in which
nonusers were compared with all ecstasy/polydrug
users and current ecstasy/polydrug users with previous
ecstasy/polydrug users.
RESULTS
Spatial span and spatial working memory
The main analysis with processing demands (simple
spatial versus SWM) within participants, and user
group (current, previous and non ecstasy user) between
participants, revealed a signiﬁcant main effect of
processing demands with lower span scores evident
under conditions of high demand, F(1,103) = 41.22,
p< 0.001. The overall group effect was also statistically
signiﬁcant, F(2,103) = 3.80, p< 0.05. Difference con-
trasts revealed that nonusers scored signiﬁcantly higher
than the combined user groups, p< 0.01, whereas
current and previous users did not differ signiﬁcantly
from each other, p> 0.05. As predicted, the interaction
between working memory processing demands and
user group was statistically signiﬁcant, F(2,103) = 3.32,
p< 0.05. Inspection of Figure 1 and Table 3 reveals that,
as anticipated, the relative impairment among users was
most evident under conditions of high workingmemory
processing demands. In order to explore the basis of the
interaction, a between‐participant analysis of varianceFigure 1. Simple spatial and spatial working memory span
Hum. Psychopharmacol Clin Exp 2011; 26: 313–321.
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Table 3. Simple spatial and spatial working memory scores for ecstasy user and nonusers
Current users Previous users Non ecstasy users p
Mean SD n Mean SD n Mean SD n Group Nonuser versus user Current versus previous
Spatial span 3.55 1.03 38 2.81 1.64 16 3.56 1.11 52 0.071 ns <0.05
Spatial working memory 2.05 1.41 38 2.00 1.46 16 2.83 1.34 52 <0.05 <0.01 ns
SD, standard deviation.
318 j. e. ﬁsk ET AL.was conducted, with the SWM scores as the dependent
variable. The overall effect of group was statistically
signiﬁcant, F(2,103) = 4.32, p < 0.05, and as predicted,
difference contrasts revealed that nonusers achieved
higher SWM scores than the combined current and
previous user groups, p < 0.01, which in turn did not
differ signiﬁcantly from each other, p > 0.05. No group
difference had been predicted for the simple spatial span
scores. However, the main effect of group did in fact
approach statistical signiﬁcance, F(2,103) = 2.71,
p = 0.071, and Tukey’s post hoc test revealed that the
difference between previous users and the other two
groups approached statistical signiﬁcance, p= 0.093 for
previous versus current and p = 0.073 for previous
versus nonusers. In both cases, previous users had
lower simple span scores.
Statistical control for IQ, weekly alcohol and daily
cigarette consumption
The groups differed signiﬁcantly on the IQ, alcohol
and cigarette measures, and these were in turn
correlated with SWM (p < 0.05 for IQ and cigarettes
and p= 0.055 for alcohol). An analysis of covariance
(ANCOVA) was conducted with group between‐
participants, the SWM score as the dependent variable,
and with IQ, alcohol and cigarette measures entered as
covariates. The overall group effect remained statisti-
cally signiﬁcant, F(2,94) = 5.16, p < 0.01, and further-
more, difference contrasts continued to show that
nonusers achieved signiﬁcantly higher scores than the
combined current and previous user groups, p < 0.01,
which in turn did not differ signiﬁcantly from each
other, p > 0.05. As covariates, the IQ and alcohol
measures accounted for statistically signiﬁcant variance
in the SWM scores with F values of 4.17, p < 0.05 and
10.58, p < 0.01, respectively on 1,94 degrees of
freedom. Daily cigarette consumption also approached
signiﬁcance as a covariate, F(1,94) = 3.20, p= 0.077.
Unexpectedly, previous users exhibited a degree of
impairment on the simple span measure. Furthermore,
IQ and alcohol consumption were signiﬁcantly
correlated with simple span, p< 0.001 and p < 0.05,
respectively. Therefore, ANCOVA was conducted
with group between‐participants, the simple spatialCopyright © 2011 John Wiley & Sons, Ltd.span score as the dependent variable, and with alcohol
consumption and IQ entered as covariates. The overall
group effect no longer approached signiﬁcance F
(2,95) = 1.65, p > 0.05. As covariates, the IQ and alcohol
measures accounted for statistically signiﬁcant vari-
ance in the simple spatial span scores with F values of
20.19, p< 0.001 and 4.85, p< 0.05, respectively on
1,95 degrees of freedom. Thus, it appears that the
difference observed between previous users and the
other two groups was substantially attributable to
group differences in IQ and alcohol consumption.
Statistical control for aspects of cannabis and
cocaine use
In order to evaluate the extent to which cannabis or
cocaine use might have been responsible for the
ecstasy/polydrug‐related SWM deﬁcits noted earlier,
ANCOVA was again conducted with group between‐
participants and the SWM score as the dependent
variable. The current frequency of cocaine use and the
total lifetime use for both cannabis and cocaine were
found to be signiﬁcantly correlated with SWM,
p < 0.05 in all cases, and were entered as covariates.
The overall group effect approached statistical signif-
icance, F(2,85) = 2.59, p= 0.081, and the difference
contrasts continued to show that nonusers achieved
signiﬁcantly higher scores than the combined current
and previous user groups, p < 0.05, which in turn did
not differ signiﬁcantly from each other, p > 0.05.DISCUSSION
The present results demonstrate that both current and
previous ecstasy users exhibit impairments in VSWM
performance. The present study’s focus on dynamic
visuospatial processing is rare among the existing
substance‐abuse research literature. To date, the focus
has been on more static visual processes with a very
substantial emphasis on visual recall. Thus, a number
of studies have found ecstasy‐related deﬁcits in the
ability to recall, reconstruct or recognise previously
viewed complex visual or geometric stimuli (Bolla
et al., 1998; Gouzoulis‐Mayfrank et al., 2000; Fox
et al., 2001; Verkes et al., 2001; Back‐Madruga et al.,Hum. Psychopharmacol Clin Exp 2011; 26: 313–321.
DOI: 10.1002/hup
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to be dose related (Bolla et al., 1998; Fox et al., 2001;
Back‐Madruga et al., 2003). In some instances,
although recognition was unimpaired, ecstasy users
took longer to conﬁrm the identity previously seen
visual targets (Gouzoulis‐Mayfrank et al., 2000;
Verkes et al., 2001). These ecstasy‐related impairments
may reﬂect the adverse effects of the drug on occipital
processes. Indeed, there is evidence that ecstasy use
may be associated with changes in the occipital lobe.
For example, in an early EEG study, Dafters et al.
(1999) found that the integrity of the visual association
pathway spanning the occipital–parietal–temporal
areas was compromised in ecstasy users. In other
research, Chang et al. (2000) conducted a neuroim-
aging study with a sample of 21 ecstasy users. Two to
three weeks following the administration of MDMA,
regional cerebral blood ﬂow among a subsample of
eight users was reduced relative to baseline across a
range of neural locations including the basal ganglia,
the visual cortex, superior parietal and the dorsolateral
prefrontal cortex (DLPFC). The authors proposed that
the subacute effects of MDMA were to increase
extracellular serotonin, which because of the neuro-
transmitter’s vasoconstrictive effects, may have given
rise to reduced regional cerebral blood ﬂow. More
recently, using PET scanning, Buchert et al. (2004)
showed that compared with polydrug controls and
nonusers of illicit drugs, current ecstasy users had
signiﬁcantly reduced serotonin transporter availability
in a number of regions including the occipital lobe (as
well as the medial temporal lobes and precentral sulcus,
mesencephalon and basal ganglia). The reduction in
the occipital lobe was dose related and larger than in
the other regions.
The potential effects of ecstasy on aspects of vision
may also be explored through experimental protocols.
For example, ecstasy users have been found to respond
differently to the tilt after‐effect illusion consistent
with atypical lateral inhibition of occipital neurons
(Brown et al., 2007; Dickson et al., 2009). Other
research has utilised transcranial magnetic stimulation.
For example, the transcranial magnetic stimulation of
the occipital cortex gives rise to subjective light
sensations at speciﬁc thresholds determined by the
minimum stimulator output intensity required to
reliably produce the sensation. These thresholds were
signiﬁcantly lower in ecstasy users compared with
controls and were negatively correlated with the
frequency of ecstasy use consistent with a dose‐related
effect (Oliveri and Calvo, 2003). Thus, to summarise it
is possible that the deﬁcits observed among ecstasy
users in the recall, reproduction and recognition ofCopyright © 2011 John Wiley & Sons, Ltd.visual stimuli may be attributable to the effects of the
drug on occipital processes.
By way of contrast, VSWM, as assessed in the
present study, involves considerably more than the
ability to recall or recognise static visual displays. It
involves the temporary storage, maintenance, process-
ing and manipulation of visuospatial information in
pursuit of goal‐related behaviours and is more reliant
on prefrontal cortical resources (Cabeza and Nyberg,
2000). The absence of any ecstasy‐related deﬁcit on
the simple Corsi‐span measure suggests that basic
serial processing of spatial sequences appears to
remain substantially intact. It has been shown that
short visual sequences, consisting of up to three
locations, can be stored and maintained in a limited
capacity store in the posterior parietal and occipital
cortices, whereas longer sequences and irregular
spatial arrangements such as the Corsi design require
DLPFC resources, which augment the posterior store
perhaps by facilitating chunking or by temporarily
storing excess spatial information (Martin et al.,
2008). Thus, the present results suggest that among
ecstasy users, this network is able to cope with basic
visuospatial maintenance tasks. This is not to say that
the posterior store is intact. It may well be that the
capacity of the store is reduced in ecstasy/polydrug
users and that performance is maintained by recruiting
additional DLPFC resources. However, working
memory tasks of the kind reported here require the
concurrent maintenance and processing of information
and are known to make greater demands on DLPFC
resources, which are involved in updating the contents
of the posterior store and organising the potentially
conﬂicting demands of the task (McCarthy et al.,
1996; Chase et al., 2008). It appears therefore that
these additional demands result in a deterioration in
performance among ecstasy/polydrug users. Whereas
such decrements have previously been demonstrated
in the processing of verbal material (Montgomery
et al., 2005; Fisk and Montgomery, 2009), the present
study provides additional evidence to show that
visuospatial processing is also affected.
Although no group differences were expected on the
simple Corsi‐type span measure, previous users
registered lower scores on this task relative to
nonusers and current users. However, the overall
group effect fell just short of statistical signiﬁcance
and in any event appeared to be due to group
differences in IQ and alcohol consumption rather than
being attributable to ecstasy use.
A number of limitations are evident in the present
research. First, following statistical controls for
concurrent cannabis and cocaine use, the overallHum. Psychopharmacol Clin Exp 2011; 26: 313–321.
DOI: 10.1002/hup
320 j. e. ﬁsk ET AL.group effect was reduced to a trend and although the
difference contrasts continued to indicate that ecstasy/
polydrug users were signiﬁcantly impaired relative to
nonusers, the possibility that the deﬁcits observed
might in part be attributable to illicit drugs other than
ecstasy or to some pre existing condition predating the
initiation of drug use cannot be excluded. Second,
there was a pronounced gender imbalance between the
groups with females predominating among nonusers
and previous ecstasy/polydrug users and males more
prevalent among current users. Third, it must be
acknowledged that as with most studies in this area, no
objective measure of recent drug use such as urinalysis
or hair analysis was used.
In summary, both current and previous ecstasy users
exhibited deﬁcits in the SWM task. With respect to the
difference contrasts, the deﬁcits remained statistically
signiﬁcant following the removal of the variance
associated with cannabis and cocaine use. In view of
the existing research evidence of ecstasy‐related
impairment in the processes supported by the occipital
and posterior parietal areas, it is possible that DLPFC
resources are recruited to bolster the capacity of the
posterior store thereby reducing the available capacity
needed to cope with the additional processing
demands that characterises the SWM task.CONFLICT OF INTEREST
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